Last10K.com

Arch Therapeutics, Inc. (ARTH) SEC Filing 10-K Annual Report for the fiscal year ending Thursday, September 30, 2021

SEC Filings

ARTH Registration of Securities

Arch Therapeutics, Inc.

CIK: 1537561 Ticker: ARTH
Document And Entity Information - USD ($)
12 Months Ended
Sep. 30, 2021
Dec. 16, 2021
Mar. 31, 2021
Document And Entity Information   
Document Type10-K  
Amendment Flagfalse  
Document Annual Reporttrue  
Document Transition Reportfalse  
Document Period End DateSep. 30, 2021  
Document Fiscal Year Focus2021  
Document Fiscal Period FocusFY  
Entity File Number000-54986  
Entity Incorporation, State or Country CodeNV  
Entity Registrant NameArch Therapeutics, Inc.  
Entity Tax Identification Number46-0524102  
Entity Address, Address Line One235 Walnut Street  
Entity Address, Address Line TwoSuite 6  
Entity Address, City or TownFramingham  
Entity Address, CountryMA  
Entity Address, Postal Zip Code01702  
City Area Code617  
Local Phone Number431-2313  
Title of 12(g) SecurityCommon Stock, par value $0.001 per share  
Entity Central Index Key0001537561  
Current Fiscal Year End Date--09-30  
Entity Well-known Seasoned IssuerNo  
Entity Voluntary FilersNo  
Entity Current Reporting StatusYes  
Entity Interactive Data CurrentYes  
Entity Filer CategoryNon-accelerated Filer  
Entity Public Float  $ 32,000,000
Trading SymbolARTH  
Entity Shell Companyfalse  
Entity Small Businesstrue  
Entity Emerging Growth Companyfalse  
Entity Common Stock, Shares Outstanding 237,169,770 

View differences made from one year to another to evaluate Arch Therapeutics, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Arch Therapeutics, Inc..

Continue

Assess how Arch Therapeutics, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Arch Therapeutics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Stockholders' Equity (Deficit)
Consolidated Statements Of Operations
2021 Registered Direct Offering
2021 Registered Direct Offering (Details)
2021 Registered Direct Offering - Additional Information (Details)
Commitments And Contingencies
Commitments And Contingencies (Details)
Convertible Notes
Convertible Notes (Details)
Derivative Liabilities
Derivative Liabilities (Tables)
Derivative Liabilities - Additional Information (Details)
Derivative Liabilities - Derivative Liabilities Using Black Scholes Model (Details)
Derivative Liabilities - Fair Value Of Derivative (Details)
Description Of Business
Income Taxes
Income Taxes (Tables)
Income Taxes - Additional Information (Details)
Income Taxes - Components Of Company's Net Deferred Tax Assets (Details)
Income Taxes - Computation Of Provision (Benefits) Income Taxes From Statutory Federal Income Tax Rate (Details)
Inventories
Inventories (Details)
Inventories (Tables)
October 2019 Registered Direct Offering
October 2019 Registered Direct Offering (Details)
Payroll Protection Program Loan
Payroll Protection Program Loan (Details)
Property And Equipment
Property And Equipment (Details)
Property And Equipment (Tables)
Property And Equipment - Additional Information (Details)
Registered Direct Offerings
Registered Direct Offerings (Details)
Risks And Uncertainties - Covid-19
Stock-Based Compensation
Stock-Based Compensation (Tables)
Stock-Based Compensation - Additional Information (Details)
Stock-Based Compensation - Restricted Stock Activity (Details)
Stock-Based Compensation - Stock Compensation Activity (Details)
Stock-Based Compensation - Weighted Average Restricted Stock (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details)
Summary Of Significant Accounting Policies (Policies)
Ticker: ARTH
CIK: 1537561
Form Type: 10-K Annual Report
Accession Number: 0001410578-21-000550
Submitted to the SEC: Fri Dec 17 2021 4:16:16 PM EST
Accepted by the SEC: Fri Dec 17 2021
Period: Thursday, September 30, 2021
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/arth/0001410578-21-000550.htm